Back
Geovax Labs Vs. Emergent BioSolutions Industry Stock Comparison
Sell
40
GOVX
Geovax Labs
Last Price:
2.58
Seasonality Move:
-3.98%
Sell
42
EBS
Emergent BioSolutions
Last Price:
9.27
Seasonality Move:
10.54%
Sell
40
Geovax Labs (GOVX)
is a Sell
Is Geovax Labs a Buy, Sell or Hold?
- The current Geovax Labs [GOVX] share price is $2.61. The Score for GOVX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- GOVX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Emergent BioSolutions (EBS)
is a Sell
Is Emergent BioSolutions a Buy, Sell or Hold?
- The current Emergent BioSolutions [EBS] share price is $9.27. The Score for EBS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- EBS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GOVX Stock Price Chart
What is Geovax Labs's stock price today?
-
The Geovax Labs share price today is $2.61
The current trend is moderately bullish and GOVX is experiencing slight selling pressure.
EBS Stock Price Chart
What is Emergent BioSolutions's stock price today?
-
The Emergent BioSolutions share price today is $9.27
The current trend is moderately bearish and EBS is experiencing selling pressure, which indicates risk of future bearish movement.
GOVX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.07 | Buy |
| Relative Strength Index (14 RSI): | 55.73 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.79 - 2.53) | Buy |
| Bollinger Bands (100): | (1.61 - 4.29) | Sell |
EBS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.45 | Buy |
| Relative Strength Index (14 RSI): | 47.81 | Sell |
| Chaikin Money Flow: | -1258022 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.64 - 10.46) | Sell |
| Bollinger Bands (100): | (7.21 - 11.01) | Buy |
GOVX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.4 | Buy |
| 20-day SMA: | 2.19 | Buy |
| 50-day SMA: | 2.43 | Buy |
| 200-day SMA: | 2.45 | Buy |
| 8-day EMA: | 2.52 | Buy |
| 20-day EMA: | 2.33 | Buy |
| 50-day EMA: | 2.5 | Buy |
| 200-day EMA: | 9.7 | Sell |
EBS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.38 | Sell |
| 20-day SMA: | 9.7 | Sell |
| 50-day SMA: | 8.63 | Buy |
| 200-day SMA: | 6.26 | Buy |
| 8-day EMA: | 10.17 | Sell |
| 20-day EMA: | 9.77 | Sell |
| 50-day EMA: | 9.16 | Buy |
| 200-day EMA: | 7.41 | Buy |
Geovax Labs Earnings Growth & GOVX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Emergent BioSolutions Earnings Growth & EBS Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.87 per share, and an increase next year of $3.99 per share.
Geovax Labs Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Emergent BioSolutions Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||